...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: coldn brought this up on the rvx board...

rvxoldtimer put this below up on the rvx board.Thank you.

 

"Yes, ZCC owns everything in Zenith but those are the shares that Zenith shareholders hold so funds into ZCC belong to the ZCC shareholders. They might not be able to be cashed in immediately if not trading at the time but the value of the ZCC shares increases according to that cash injection. 

As far as cashing in on that sale or such, if RVX carries through as they have posed to us in the past, ZCC shareholders would, at or immediately prior to a sale, receive proportionate shares in ZEL to their ZCC holdings. The purchaser would then be buying the ZEL shares so the shareholders would receive the funds directly from the purchase. The shareholder would still own their ZCC shares and ZCC would hold collectively the RVX royalty preferred shares."

Share
New Message
Please login to post a reply